#692 on the rich list of 14,644 insiders
Stephen Hoge
President at Moderna. Based in Cambridge, Massachusetts.
$295M
in disclosed stock, +$6.0M (+2.06%) today
Live prices, last trade 2:32 PM ET
- Rank
- 692nd of 14,644
- Companies held
- 1
- Largest holding
- MRNA, 100.0% of total
- Latest SEC filing
- Nov 17, 2026
What the $295M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Moderna MRNA Common Stock | Directly | 1,311,095 | $200.85 | $263M | 89.4% | Form 4, Nov 17, 2026 |
| Moderna MRNA Common Stock | Through Trust | 151,933 | $200.85 | $30.5M | 10.4% | Form 4, Nov 16, 2026 |
| Moderna MRNA Common Stock | Through Valhalla, LLC | 4,116 | $200.85 | $827K | 0.3% | Form 4, Nov 16, 2026 |
Share counts are the amounts Stephen Hoge reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Sold | MRNA | 33,976 | $211.45 | $7.2M | View |
| Nov 17, 2026 | Sold | MRNA | 5,082 | $212.57 | $1.1M | View |
| Nov 17, 2026 | Sold | MRNA | 157 | $214.19 | $34K | View |
| Nov 16, 2026 | Sold | MRNA | 39,160 | $219.66 | $8.6M | View |
| Oct 15, 2026 | Sold | MRNA | 39,145 | $220.72 | $8.6M | View |
| Oct 14, 2026 | Sold | MRNA | 38,774 | $213.47 | $8.3M | View |
| Oct 14, 2026 | Sold | MRNA | 450 | $214.15 | $96K | View |
| Sep 15, 2026 | Sold | MRNA | 40,281 | $146.07 | $5.9M | View |
| Sep 14, 2026 | Sold | MRNA | 40,294 | $144.13 | $5.8M | View |
| Jul 15, 2026 | Sold | MRNA | 53,336 | $67.60 | $3.6M | View |
| Jun 15, 2026 | Sold | MRNA | 53,336 | $51.37 | $2.7M | View |
| May 15, 2026 | Sold | MRNA | 53,336 | $48.40 | $2.6M | View |
| Feb 23, 2026 | Sold | MRNA | 160,009 | $48.84 | $7.8M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 689 | Frederic Simon Director, JFrog. Sunnyvale, CA | $298M |
| 690 | Andrew Reed Director, Figma. Menlo Park, CA | $295M |
| 691 | Carmen C. Murphy 10% owner, 1st Source. South Bend, IN | $295M |
| 692 | Stephen Hoge President, Moderna. Cambridge, MA | $295M |
| 693 | Irwin N. Gold CO-CHAIRMAN, Houlihan Lokey. Los Angeles, CA | $294M |
| 694 | David Wilcox Executive Chairman, Evolution Metals & Technologies. West Palm Beach, FL | $294M |
| 695 | Scott G. Stephenson CEO and President, Verisk Analytics. Framingham, MA | $292M |
Other Moderna insiders
All MRNA insiders- Robert Langer$2.31BDirector. #137 overall
- Stephane Bancel$1.29BChief Executive Officer. #211 overall
- Noubar B. Afeyan$447MDirector. #519 overall
- Paul Sagan$99.2MDirector. #1519 overall
- Juan Andres$25.1MChief Operating Officer. #4246 overall
- Shannon Thyme Klinger$16.3MChief Legal Officer. #6038 overall
Questions
How much stock does Stephen Hoge own?
Stephen Hoge holds $294,675,872 in listed stock based on SEC filings and current prices, mostly Moderna (MRNA). That ranks 692nd on the Stock Rich List.
Is this Stephen Hoge's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Stephen Hoge last buy or sell stock?
The most recent open-market trade on file is a sale of 33,976 MRNA shares on Nov 17, 2026 at $211.45.